I have significant new information, which is best presented next...

First 10 Last

Share
Profile

Follow
BoroBoyinoz

7,577 Posts.

1289

18/02/18

09:06

Post #: 31135141
Share

Originally posted by needle ↑

The current management group, right from the time of their commencement with the company - understand the massive potential here, and what is at stake with Cantrixil. (in my view)

Indeed this breakthrough cancer drug is the very reason our high profile management group joined the company. The work of Dr Mor, which they understand to a much greater level than shareholders, is the prime reason for confidence in the drug. The model is unique, extremely robust and value conclusive. (my view)

It would follow than......... if I am correct and the stakes are indeed very high - this is the reason that previous management were moved on. After a settling in period "they" had the power to remove certain people from the company and thats what happened. The perception right or wrong, is that a former $10m PA Eli Elly and others new to the company, could do a better job.

I have significant new information, which is best presented next time the company has a share price run. So back to my theory.....if that is the reason why the previous CEO left, why are we at just over US$20m cap, when our deputy chairman earn' t that amount in 2 years.

Why are these people with the company, if we are not sitting on a major cancer breakthrough ? Why does the market not see what is so plainly apparent, given the role taken up by a big Pharma executive in our company.

Well I can see clearly what lays ahead for shareholders. Excitement such that you will see once only.

Expand

I have significant new information, which is best presented next time the company has a share price run.

Well I can see clearly what lays ahead for shareholders. Excitement such that you will see once only.

Do the rules of continuous disclosure apply to anonymous Hot Copper Posters, or are you going to keep us in suspense?

KZA Price at posting: 57.0¢ Sentiment: Hold Disclosure: Held
9 Upvote

0 Great analysis

Reply

Top Stories

NTI

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

CKA

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

SLS

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

RCE

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

BUX

Buxton projects new graphite province discovery at WA Narryer play

BCI

BCI reaches close of funding facility for salt-first part of Mardie project

WCN

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

COD

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

ACW

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

There are more pages in this discussion • 1 more message in this thread...

First 10 Last

Add KZA (ASX) to my watchlist

I have significant new information, which is best presented next...

Top Stories

Neurotech knocked back by FDA as agency declares target condition not rare enough for special status

Cokal upgrades infrastructure for BBM ramp-up in Indonesia

Week 40 Wrap: China's nonsensical stimmy hype wanes (shocking!); HotCopper's picks; oil & inflation

Solstice Minerals to ramp up drilling campaign at Yarri Gold Project

Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger

Buxton projects new graphite province discovery at WA Narryer play

BCI reaches close of funding facility for salt-first part of Mardie project

White Cliff jumps 24% on 'bonanza grade' copper rock chips at Rae project, Canada

Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Featured News